Suchergebnisse - "Armuzzi, Alessandro"

PubPharm (25)

1

Therapeutic sequencing in inflammatory bowel disease : Determining the optimal position of vedolizumab for long-term Crohn's disease control using real-world evidence

enthalten in: United European gastroenterology journal | 2024

von Louis, E. | Litkiewicz, M. | Agboton, C. | +1

2

Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials

enthalten in: BMC gastroenterology | 2024

von Peyrin-Biroulet, L. | Arkkila, P. | Armuzzi, A. | +14

3

Effectiveness and Safety of Switching from Intravenous to Subcutaneous Vedolizumab Formulation in Inflammatory Bowel Disease Patients in Clinical Remission

enthalten in: Journal of gastrointestinal and liver diseases : JGLD | 2023

von Parisio, L. | Settanni, C. | Varca, S. | +14

4

Vedolizumab for the Treatment of Chronic Pouchitis

enthalten in: The New England journal of medicine | 2023

von Travis, S. | Silverberg, M. | Danese, S. | +45

5

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn's Disease : A Multi-Center Retrospective Cohort Study

enthalten in: Journal of clinical medicine | 2023

von Albshesh, A. | Bannon, L. | Sharar Fischler, T. | +15

6

The role of ustekinumab and vedolizumab in management of extra intestinal manifestations in inflammatory bowel disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Katsanos, K. | Fousekis, F. | Armuzzi, A.

CommentOn: Dig Liver Dis. 2023 Feb;55(2):223-229. - PMID 36241535

7

Endoscopic Postoperative Recurrence in Crohn's Disease After Curative Ileocecal Resection with Early Prophylaxis by Anti-TNF, Vedolizumab or Ustekinumab : A Real-World Multicentre European Study

enthalten in: Journal of Crohn's & colitis | 2022

von Yanai, H. | Kagramanova, A. | Knyazev, O. | +68

8

Editorial : effectiveness and safety of vedolizumab in a matched cohort of elderly and non-elderly patients with inflammatory bowel disease-the IG-IBD LIVE study. Authors' reply

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Pugliese, D. | Privitera, G. | Armuzzi, A.

CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):95-109. - PMID 35876062

9

An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha Inhibitors

enthalten in: The American journal of gastroenterology | 2022

von Onali, S. | Pugliese, D. | Caprioli, F. | +28

10

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG-IBD LIVE study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Pugliese, D. | Privitera, G. | Crispino, F. | +58

CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):731-732. - PMID 35879894